Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Matteo Bassetti, Alessia Carnelutti, Nadia Castaldo & Maddalena Peghin. (2019) Important new therapies for methicillin-resistant Staphylococcus aureus. Expert Opinion on Pharmacotherapy 20:18, pages 2317-2334.
Read now
Read now
A. Khan, B. Wilson & I. M. Gould. (2018) Current and future treatment options for community-associated MRSA infection. Expert Opinion on Pharmacotherapy 19:5, pages 457-470.
Read now
Read now
Oludotun A. Phillips & Leyla H. Sharaf. (2016) Oxazolidinone antimicrobials: a patent review (2012-2015). Expert Opinion on Therapeutic Patents 26:5, pages 591-605.
Read now
Read now
Ramya Kollipara, Christopher Downing, Michael Lee, Jacqueline Guidry, Stephen Curtis & Stephen Tyring. (2014) Current and emerging drugs for acute bacterial skin and skin structure infections: an update. Expert Opinion on Emerging Drugs 19:3, pages 431-440.
Read now
Read now
Eric Beresford, Donald Biek, Alena Jandourek, Yogesh Mawal, Todd Riccobene & H David Friedland. (2014) Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections. Expert Review of Clinical Pharmacology 7:2, pages 123-135.
Read now
Read now
Articles from other publishers (32)
Dan Zhang, Yasi Xu, Xiang Wang, Leping Hou, Mengyu Xing, Shuang Xu, Rui Guo & Ying Luo. (2023) Risk factors for thrombocytopenia in patients receiving linezolid therapy: a systematic review and meta-analysis. European Journal of Clinical Pharmacology.
Crossref
Crossref
Bisma Jan, Rafia Jan, Suhaib Afzal, Mehrose Ayoub & Mubashir Hussain Masoodi. 2023. Non-traditional Approaches to Combat Antimicrobial Drug Resistance. Non-traditional Approaches to Combat Antimicrobial Drug Resistance
79
100
.
Susmita Das, Sukhvinder Singh, Sarthak Satpathy, Manoj Bhasin & Ashok Kumar. (2022) Transcriptomics and systems biology identify non-antibiotic drugs for the treatment of ocular bacterial infection. iScience 25:9, pages 104862.
Crossref
Crossref
Deyuan You, Yuexiang Su, Xuri Sun, Jianbao Wang, Yuxin Zheng & Yuqi Liu. (2022) Linezolid in the treatment of severe intraabdominal infection: A STROBE-compliant retrospective study. Medicine 101:33, pages e30038.
Crossref
Crossref
Mulemba Tillika Samutela, Geoffrey Kwenda, Edgar Simulundu, Panji Nkhoma, Hideaki Higashi, Andrew Frey, Matthew Bates & Bernard M. Hang'ombe. (2021) Pigs as a potential source of emerging livestock-associated Staphylococcus aureus in Africa: a systematic review. International Journal of Infectious Diseases 109, pages 38-49.
Crossref
Crossref
Donald J. AbrahamSebastian A. Testero, Leticia I. Llarrull, Jed F. Fisher & Shahriar Mobashery. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
188
.
Sergey V. Sapozhnikov, Alina E. Sabirova, Nikita V. Shtyrlin, Anastasia Y. Druk, Mariya N. Agafonova, Milana N. Chirkova, Renata R. Kazakova, Denis Y. Grishaev, Tatyana V. Nikishova, Elena S. Krylova, Elena V. Nikitina, Airat R. Kayumov & Yurii G. Shtyrlin. (2021) Design, synthesis, antibacterial activity and toxicity of novel quaternary ammonium compounds based on pyridoxine and fatty acids. European Journal of Medicinal Chemistry 211, pages 113100.
Crossref
Crossref
Sergey V. Sapozhnikov, Roman S. Pavelyev, Nikita V. Shtyrlin & Yurii G. Shtyrlin. Synthetic route optimization of pyridosept antiseptic drug candidate. Synthetic route optimization of pyridosept antiseptic drug candidate.
De Zhou, Ting Shi, Shuqi Zhao, Jingjing Zhu, Lixia Zhu, Xiudi Yang, Wanzhuo Xie & Xiujin Ye. (2020) Linezolid is safe on platelet count for AML patients during myelosuppression after consolidation chemotherapy. Journal of Clinical Pharmacy and Therapeutics 45:4, pages 755-758.
Crossref
Crossref
Go Wun Choi, Ju-Yeun Lee, Min Jung Chang, Young Kyung Kim, Yoonsook Cho, Yun Mi Yu & Euni Lee. (2019) Risk factors for linezolid-induced thrombocytopenia in patients without haemato-oncologic diseases. Basic & Clinical Pharmacology & Toxicology 124:2, pages 228-234.
Crossref
Crossref
Diana Laverde, Ines Probst, Felipe Romero-Saavedra, Andrea Kropec, Dominique Wobser, Walter Keller, Elisabeth Grohmann & Johannes Huebner. (2017) Targeting Type IV Secretion System Proteins to Combat Multidrug-Resistant Gram-positive Pathogens. The Journal of Infectious Diseases 215:12, pages 1836-1845.
Crossref
Crossref
Silvia D'ArezzoAntonio MazzarelliCarolina VendittiCarla NisiiNicola PetrosilloChiara De GiuliAntonella VulcanoMaria Grazia PagliaEugenio BordiAntonino Di CaroFabrizio Taglietti. (2017) Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays. Microbial Drug Resistance 23:4, pages 507-515.
Crossref
Crossref
Julie Kempf & Andreea R. Schmitzer. (2017) Metal-Organic Synthetic Transporters (MOST): Efficient Chloride and Antibiotic Transmembrane Transporters. Chemistry - A European Journal 23:26, pages 6441-6451.
Crossref
Crossref
Juwon Yim, Jordan R. Smith & Michael J. Rybak. (2017)
Role of Combination Antimicrobial Therapy for Vancomycin-Resistant
Enterococcus faecium
Infections: Review of the Current Evidence
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:5, pages 579-592.
Crossref
Crossref
Jordan R. Smith, Kimberly C. Claeys, Evan J. Zasowski, Juwon Yim & Michael J. Rybak. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
307
317
.
Yvonne J. Burnett, Kelly Echevarria & Kristi A. Traugott. (2016) Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia. Annals of Pharmacotherapy 50:12, pages 1051-1059.
Crossref
Crossref
Malgorzata Mikulska & Claudio Viscoli. 2016. Transplant Infections. Transplant Infections
335
355
.
Helio S. Sader, David J. Farrell, Robert K. Flamm & Ronald N. Jones. (2015) Analysis of 5-year trends in daptomycin activity tested against Staphylococcus aureus and enterococci from European and US hospitals (2009–2013). Journal of Global Antimicrobial Resistance 3:3, pages 161-165.
Crossref
Crossref
Lucy L. Furfaro, O. Brad Spiller, Jeffrey A. Keelan & Matthew S. Payne. (2015) In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin. International Journal of Antimicrobial Agents 46:3, pages 319-324.
Crossref
Crossref
Sergio E. Trevino & Marin H. Kollef. (2015) Management of Infections with Drug-Resistant Organisms in Critical Care. Clinics in Chest Medicine 36:3, pages 531-541.
Crossref
Crossref
Armando Gonzalez-Ruiz, Panayiotis Gargalianos-Kakolyris, Artur Timerman, Jayanta Sarma, Víctor José González Ramallo, Kamel Bouylout, Uwe Trostmann, Rashidkhan Pathan & Kamal Hamed. (2015) Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry. Advances in Therapy 32:6, pages 496-509.
Crossref
Crossref
Rodrigo E. Mendes, Patricia A. Hogan, Jennifer M. Streit, Ronald N. Jones & Robert K. Flamm. (2015)
Update on Linezolid
In Vitro
Activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013
. Antimicrobial Agents and Chemotherapy 59:4, pages 2454-2457.
Crossref
Crossref
Jingru Meng, Gonghao He, Hui Wang, Min Jia, Xue Ma, Fei Da, Ning Wang, Zheng Hou, Xiaoyan Xue, Mingkai Li, Ying Zhou & Xiaoxing Luo. (2014) Reversion of antibiotic resistance by inhibiting mecA in clinical methicillin-resistant Staphylococci by antisense phosphorothioate oligonucleotide. The Journal of Antibiotics 68:3, pages 158-164.
Crossref
Crossref
George G. Zhanel, Riley Love, Heather Adam, Alyssa Golden, Sheryl Zelenitsky, Frank Schweizer, Bala Gorityala, Philippe R. S. Lagacé-Wiens, Ethan Rubinstein, Andrew Walkty, Alfred S. Gin, Matthew Gilmour, Daryl J. Hoban, Joseph P. Lynch3rd3rd & James A. Karlowsky. (2015) Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens. Drugs 75:3, pages 253-270.
Crossref
Crossref
C. S. Ciobanu, S. L. Iconaru, C. L. Popa, M. Motelica-Heino & D. Predoi. (2015) Evaluation of Samarium Doped Hydroxyapatite, Ceramics for Medical Application: Antimicrobial Activity. Journal of Nanomaterials 2015, pages 1-11.
Crossref
Crossref
Victor Fedorenko, Olga Genilloud, Liliya Horbal, Giorgia Letizia Marcone, Flavia Marinelli, Yossi Paitan & Eliora Z. Ron. (2015) Antibacterial Discovery and Development: From Gene to Product and Back. BioMed Research International 2015, pages 1-16.
Crossref
Crossref
Cristina Vazquez-Guillamet & Marin H Kollef. (2014) Treatment of gram - positive infections in critically ill patients. BMC Infectious Diseases 14:1.
Crossref
Crossref
Natasha E. Holmes & Benjamin P. Howden. (2014) Whatʼs new in the treatment of serious MRSA infection?. Current Opinion in Infectious Diseases 27:6, pages 471-478.
Crossref
Crossref
Swapnil Ranotkar, Parveen Kumar, Shubhranshu Zutshi, Krishna Shastrula Prashanth, Babul Bezbaruah, Jay Anand & Mangala Lahkar. (2014) Vancomycin-resistant enterococci: Troublemaker of the 21st century. Journal of Global Antimicrobial Resistance 2:4, pages 205-212.
Crossref
Crossref
E. McElvania TeKippe, B. S. Thomas, G. A. Ewald, S. J. Lawrence & C.-A. D. Burnham. (2014) Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale. European Journal of Clinical Microbiology & Infectious Diseases 33:12, pages 2199-2205.
Crossref
Crossref
Matthias Scheb-Wetzel, Manfred Rohde, Alicia Bravo & Oliver Goldmann. (2014) New Insights into the Antimicrobial Effect of Mast Cells against Enterococcus faecalis. Infection and Immunity 82:11, pages 4496-4507.
Crossref
Crossref
Dmitrijs Zhulenkovs, Zhanna Rudevica, Kristaps Jaudzems, Maris Turks & Ainars Leonchiks. (2014) Discovery and structure–activity relationship studies of irreversible benzisothiazolinone-based inhibitors against Staphylococcus aureus sortase A transpeptidase. Bioorganic & Medicinal Chemistry 22:21, pages 5988-6003.
Crossref
Crossref